Health Archives - Barbados Today

Meta investigated over illicit drug sales: report

United States authorities are investigating Meta over its role in the illicit sale of medications, The Wall Street Journal reported Saturday.

Citing documents and people close to the matter, the American business daily said prosecutors in the southern US state of Virginia are looking into whether the company’s social media platforms are facilitating and profiting from the illegal sale of drugs.

Prosecutors have asked for records on “violative drug content on Meta’s platforms and/or the illicit sale of drugs via Meta’s platforms,” according to copies of subpoenas reviewed by The Wall Street Journal.

The Food and Drug Administration (FDA) has been helping with the investigation, the paper reported.

“The sale of illicit drugs is against our policies and we work to find and remove this content from our services,” Meta told the Journal in a statement, adding that it “proactively cooperates” with law enforcement to help combat the sale of illicit drugs.

Contacted by AFP on Saturday morning, neither the FDA nor Meta would comment.

On Friday, Nick Clegg, president of global affairs at Meta, said the company had joined an effort alongside the US State Department, the United Nations and Snapchat to help disrupt the sale of synthetic drugs online and educate users about the risks.

“The opioid epidemic is a major public health issue that requires action from all parts of US society,” Clegg wrote on X.

More than 700,000 people died of opioid overdoses between 1999 and 2022, according to the US Centers for Disease Control and Prevention.

SOURCE: AFP

The post Meta investigated over illicit drug sales: report appeared first on Barbados Today.

1 year 1 month ago

Health, World

Health Archives - Barbados Today

Corporate Barbados, Health Ministry join forces to combat rat problem

Some south coast businesses and the Ministry of Health and Wellness have joined forces to reduce the rodent population from the area that stretches from the Richard Haynes Boardwalk to Oistins, Christ Church.

It is part of the second phase of the Ministry’s Build Them Out, Starve Them Out, Kill Them Out, rat reduction campaign. The partnership will see businesses adopt signs and garbage bins that would encourage members of the public to refrain from littering.

The bins are being placed along the south coast. The campaign also involves correcting the businesses’ garbage disposal methods to help “starve out” the rats.

Senior Environmental Health Officer at the Randal Phillips Polyclinic in Oistins, Trevor Taylor, explained that health officials discovered some deficiencies in the way businesses were storing garbage, which encouraged the proliferation of rats because these businesses became a food source.

“We engaged the business owners along the coast on how they should store garbage appropriately in bins and garbage houses and have it removed at appropriate times. We also found there was a lot of litter around the boardwalk coming from persons using that area,” Taylor stated.

He added: “It is not only about rats but about the outlook for Barbados as a clean destination and protecting the marine environment. I like spearfishing and the amount of litter you find in the sea is amazing. It is not just for businesses to get involved; it is for everybody. Just take your garbage and place it in bins.”

The Senior Environmental Health Officer said one aspect of the campaign, which started in August, last year, is to ‘rat proof’ the garbage bins, which is the “build out” component. However, he pointed out that this was still a work in progress.

Taylor noted that the bins health inspectors are aiming to have placed along the south coast will have a key, so business owners can open and lock the bins, when necessary, to keep out rodents. In the meantime, health inspectors continue to bait along the south coast, the “kill them out” phase of the campaign.

So far, he said two well-known businesses, Kentucky Fried Chicken and Pirates Inn, have partnered with the Ministry to combat littering and rodents on the south coast, with a number of hotels expressing an interest in coming on board.

Businesses interested in partnering with the Ministry of Health and Wellness in its rodent reduction campaign may contact Taylor at the Randal Philips Polyclinic at telephone number 536-4314.

SOURCE: BGIS

The post Corporate Barbados, Health Ministry join forces to combat rat problem appeared first on Barbados Today.

1 year 1 month ago

Health, Local News

Health | NOW Grenada

SAASS supporter dies after medical episode at Intercol

Vernessa Harford collapsed during the Republic Bank Intercol Championship (Intercol) on Thursday, 14 March and later died at The General Hospital

View the full post SAASS supporter dies after medical episode at Intercol on NOW Grenada.

Vernessa Harford collapsed during the Republic Bank Intercol Championship (Intercol) on Thursday, 14 March and later died at The General Hospital

View the full post SAASS supporter dies after medical episode at Intercol on NOW Grenada.

1 year 1 month ago

Health, Sports, Tribute, curlan campbell, dianne abel jeffery, dwain thomas, intercol, ritchie harford, saass, st andrew’s anglican secondary school, tessa st cyr, vernessa harford

Health – Dominican Today

Dominican Republic receives human tissue for children with severe burns

Santo Domingo – The Dominican Republic managed a donation of 3,600 cm2 of Liolized Human Skin Tissue, donated by the Government of Mexico, to be used in caring for patients admitted to Dr. Thelma Rosario’s burn unit.

Santo Domingo – The Dominican Republic managed a donation of 3,600 cm2 of Liolized Human Skin Tissue, donated by the Government of Mexico, to be used in caring for patients admitted to Dr. Thelma Rosario’s burn unit.

These are minors affected by severe burns during an explosion at the Salcedo carnival a week ago. This action will improve the health of patients who remain in critical condition and are admitted to the intensive care unit at the Arturo Grullón Regional Children’s Hospital in Santiago. The management was carried out through the Ministry of Public Health in coordination with the Ministry of Foreign Affairs (MIREX), the National Health Service (SNS), the National Institute for Transplant Coordination (INCORT), and the Embassy of the Dominican Republic in Mexico.

The coordination was made with the Ministry of Health, the Federal Commission for the Protection against Sanitary Risks, and the Authorization Commission of Mexico. The liquefied tissues were transported by the airline Aeromexico and guarded by the minister counselor, Orlando Rodriguez. They were received by the Regional Director of North Central Health, Dr. Manuel Lora, and the referred health center authorities.

This type of freeze-dried tissue is used as a temporary cover for wounds caused by burns, diabetic ulcers, varicose veins, decubitus, leprosy, and others.

Current situation
Until yesterday afternoon, the four minors admitted to the Robert Reid Cabral Hospital were taken to the conventional operating room area to be treated. Although this hospital has no burn area, care is being maximized.

Of the seven minors who were admitted to the burn unit of the Arturo Grullón hospital, one was discharged, two died, and four are in critical health conditions. The information was given by Dr. Yocasta Lara, Director of Hospitals of the National Health Service. A state of mourning and grief affected the community of Salcedo, as 19 people were injured with burns.

1 year 1 month ago

Health, Local

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Understanding Varicose Veins: Signs, Causes, and Treatment - Dr Santosh Patil

Veins can develop, expand, and overflow with blood when a person has varicose veins, also known as varicose or varicosities. They are usually greenish or bluish-purple in colour, look bloated and elevated, and could cause pain.

Varicose veins are a common disease that affects millions of people worldwide. These larger, protruding veins, typically located in the legs and feet, can cause problems that go beyond aesthetics.

Signs and symptoms

Varicose veins are usually identified by visible, expanding, twisting veins that can be blue or purple in colour. Apart from their appearance, people with varicose veins can feel sensations like aching, throbbing, or heaviness in their legs, particularly after long periods of standing or sitting. These can further progress to cause skin darkening, eczema, and skin ulcerations.

Causes of Varicose Veins

Several factors contribute to the development of varicose veins, such as:

1. Genetics and family history play an important role, as a tendency to weaken vein valves is passed down through generations.

2. Obesity, lack of physical activity, and extended sitting or standing all raise the chance of developing varicose veins.

3. Hormonal changes during pregnancy or menopause can weaken vein walls, leading to the development of varicose veins.

4. Pregnancy, menopause, age over 50, and standing for long periods of time can cause varicose veins.

Risk Factors

Senior citizens and women are more likely to get varicose veins. Occupations that involve prolonged standing or sitting may potentially raise the risk of getting varicose veins.

Diagnosis

Varicose veins are normally diagnosed by a doctor's physical examination. In some circumstances, imaging tests like colour Doppler ultrasonography may be used to check the severity of the disease and any underlying issues.

Prevention

While not all cases of varicose veins can be avoided, certain lifestyle changes can help lower the risk, such as:

1. Regular exercise

2. A healthy weight and exercise are needed for better circulation.

3. Avoiding prolonged sitting or standing can help improve vein health.

4. Use compression socks or stockings.

Treatment Options

The severity of varicose veins affects the appropriate treatment. Compression stockings are frequently advised to help with circulation and reduce symptoms. Options such as:

1. Sclerotherapy

2. Endovenous laser therapy (EVLT)

3. Glue embolization (Venaseal)

4. Surgical treatments to remove or close problematic veins are among the additional treatment possibilities.

Living with varicose veins can be difficult, both physically and emotionally. People can control symptoms while maintaining a high quality of life through meditation, yoga, exercise, and implementing lifestyle changes. If varicose vein problems persist or worsen over time, then you should see a doctor. Early medical attention can assist in avoiding problems while improving overall vein health.

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.

1 year 1 month ago

Health Dialogues

Health | NOW Grenada

Kidney disease and water/fluid intake

“If you are diagnosed with chronic kidney disease, your water intake may differ from what is normally recommended”

View the full post Kidney disease and water/fluid intake on NOW Grenada.

“If you are diagnosed with chronic kidney disease, your water intake may differ from what is normally recommended”

View the full post Kidney disease and water/fluid intake on NOW Grenada.

1 year 1 month ago

Health, PRESS RELEASE, american kidney fund kidney kitchen, fluid, grenada food and nutrition council, kidney disease, Water

Health | NOW Grenada

Care-Transition Clinic accepting applications for nursing programmes

Care-Transition Clinic is accepting applications for its General Nursing Programme Associate Degree, expected to commence in August 2024

1 year 1 month ago

Health, PRESS RELEASE, ambika Joseph, care-transition clinic, curlan campbell, nurse, nursing and midwives council of grenada

Health | NOW Grenada

Together against sexual violence: NNP Women’s Arm speaks out

“The NNP Women’s Arm pledges to continue our work in creating safer spaces for women and girls”

View the full post Together against sexual violence: NNP Women’s Arm speaks out on NOW Grenada.

“The NNP Women’s Arm pledges to continue our work in creating safer spaces for women and girls”

View the full post Together against sexual violence: NNP Women’s Arm speaks out on NOW Grenada.

1 year 1 month ago

Business, Carriacou & Petite Martinique, Community, Crime, Health, PRESS RELEASE, Tribute, Youth, carriacou, esther patterson, nnp, nnp women's arm, sexual violence

KFF Health News

KFF Health News' 'What the Health?': Maybe It’s a Health Care Election After All

The Host

Julie Rovner
KFF Health News


@jrovner


Read Julie's stories.

The Host

Julie Rovner
KFF Health News


@jrovner


Read Julie's stories.

Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to Z,” now in its third edition.

The general election campaign for president is (unofficially) on, as President Joe Biden and former President Donald Trump have each apparently secured enough delegates to become his respective party’s nominee. And health care is turning out to be an unexpectedly front-and-center campaign issue, as Trump in recent weeks has suggested he may be interested in cutting Medicare and taking another swing at repealing and replacing the Affordable Care Act.

Meanwhile, the February cyberattack of Change Healthcare, a subsidiary of insurance giant UnitedHealth Group, continues to roil the health industry, as thousands of hospitals, doctors, nursing homes, and other providers are unable to process claims and get paid.

This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Joanne Kenen of Johns Hopkins University and Politico Magazine, and Margot Sanger-Katz of The New York Times.

Panelists

Anna Edney
Bloomberg


@annaedney


Read Anna's stories.

Joanne Kenen
Johns Hopkins Bloomberg School of Public Health and Politico


@JoanneKenen


Read Joanne's articles.

Margot Sanger-Katz
The New York Times


@sangerkatz


Read Margot's stories.

Among the takeaways from this week’s episode:

  • It is unclear exactly what Trump meant in his recent remarks about possible cuts to Medicare and Social Security, though his comments provided an opening for Biden to pounce. By running as the candidate who would protect entitlements, Biden could position himself well, particularly with older voters, as the general election begins.
  • Health care is shaping up to be the sleeper issue in this election, with high stakes for coverage. The Biden administration’s expanded subsidies for ACA plans are scheduled to expire at the end of next year, and the president’s latest budget request highlights his interest in expanding coverage, especially for postpartum women and for children. Plus, Republicans are eyeing what changes they could make should Trump reclaim the presidency.
  • Meanwhile, Republicans are grappling with an internal party divide over access to in vitro fertilization, and Trump’s mixed messaging on abortion may not be helping him with his base. Could a running mate with more moderate perspectives help soften his image with voters who oppose abortion bans?
  • A federal appeals court ruled that a Texas law requiring teenagers to obtain parental consent for birth control outweighs federal rules allowing teens to access prescription contraceptives confidentially. But concerns that if the U.S. Supreme Court heard the case a conservative-majority ruling would broaden the law’s impact to other states may dampen the chances of further appeals, leaving the law in effect. Also, the federal courts are making it harder to file cases in jurisdictions with friendly judges, a tactic known as judge-shopping, which conservative groups have used recently in reproductive health challenges.
  • And weeks later, the Change Healthcare hack continues to cause widespread issues with medical billing. Some small providers fear continued payment delays could force them to close, and it is possible that the hack’s repercussions could soon block some patients from accessing care at all.

Also this week, Rovner interviews Kelly Henning of Bloomberg Philanthropies about a new, four-part documentary series on the history of public health, “The Invisible Shield.”

Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too:

Julie Rovner: The Washington Post’s “Navy Demoted Ronny Jackson After Probe Into White House Behavior,” by Dan Diamond and Alex Horton.

Joanne Kenen: The Atlantic’s “Frigid Offices Might Be Killing Women’s Productivity,” by Olga Khazan.

Margot Sanger-Katz: Stat’s “Rigid Rules at Methadone Clinics Are Jeopardizing Patients’ Path to Recover From Opioid Addiction,” by Lev Facher.

Anna Edney: Scientific American’s “How Hospitals Are Going Green Under Biden’s Climate Legislation,” by Ariel Wittenberg and E&E News.

Also mentioned on this week’s podcast:

Click to open the transcript

Transcript: Maybe It’s a Health Care Election After All

[Editor’s note: This transcript was generated using both transcription software and a human’s light touch. It has been edited for style and clarity.]

Julie Rovner: Hello, and welcome back to “What the Health?” I’m Julie Rovner, chief Washington correspondent for KFF Health News, and I’m joined by some of the best and smartest health reporters in Washington. We’re taping this week on Thursday, March 14, at 10 a.m. Happy Pi Day, everyone. As always, news happens fast and things might have changed by the time you hear this, so here we go. We are joined today via video conference by Margot Sanger-Katz of The New York Times.

Margot Sanger-Katz: Good morning, everybody.

Rovner: Anna Edney of Bloomberg News.

Anna Edney: Hi there.

Rovner: And Joanne Kenen of the Johns Hopkins University and Politico Magazine.

Joanne Kenen: Hey, everyone.

Rovner: Later in this episode we’ll have my interview with Dr. Kelly Henning, head of the public health program at Bloomberg Philanthropies. She’ll give us a preview of the new four-part documentary series on the history of public health called “The Invisible Shield;” It premieres on PBS March 26. But first this week’s news. We’re going to start here in Washington with the annual State of the Union / budget dance, which this year coincides with the formal launch of the general election campaign, with both President Biden and former President Donald Trump having clinched their respective nominations this week.

Despite earlier claims that this year’s campaign would mostly ignore health issues, that’s turning out not so much to be the case. Biden in his speech highlighted reproductive health, which we’ll talk about in a minute, as well as prescription drug prices and the Affordable Care Act expansions. His proposed budget released on Monday includes suggestions of how to operationalize some of those proposals, including expanding Medicare’s drug negotiating powers. Did anything in particular in the speech or the budget jump out at any of you? Anything we weren’t expecting.

Edney: I wouldn’t say there was anything that I wasn’t expecting. There were things that I was told I should not expect and that I feel like I’ve been proven right, and so I’m happy about that, and that was the Medicare drug price negotiation. I thought that that was a win that he was going to take a lap on during the State of the Union, and certainly he did. And he’s also talking about trying to expand it, although that seems to face an extremely uphill battle, but it’s a good talking point.

Rovner: Well, and of course the expanded subsidies from the ACA expire at the end of next year. I imagine there’s going to be enough of a fight just to keep those going, right?

Edney: Yeah, certainly. I think people really appreciate the subsidies. If those were to go away, then the uninsured rate could go up. It’s probably an odd place in a way for Republicans, too, who are talking about, again, still in some circles, in some ways, getting rid of Obamacare. We’re back at that place even though I don’t think anyone thinks that’s entirely realistic.

Rovner: Oh, you are anticipating my next question, which is that former President Trump, who is known for being all over the place on a lot of issues, has been pretty steadfast all along about protecting Medicare and Social Security, but he’s now backing away from even that. In an interview on CNBC this week, Trump said, and I’m quoting, “There is a lot you can do in terms of entitlements in terms of cutting” — which his staff said was referring to waste and fraud, but which appears to open that up as a general election campaign issue. Yes, the Biden people seem to be already jumping on it.

Sanger-Katz: Yes. They could not be more excited about this. I think this has been an issue that Biden has really wanted to run on as the protector of these programs for the elderly. He had this confrontation with Congress in the State of the Union last year, as you may remember, in which he tried to get them to promise not to touch these programs. And I think his goal of weaponizing this issue has been very much hindered by Trump’s reluctance to take it on. I think there are Republicans, certainly in Congress, and I think that we saw during the presidential primary some other candidates for president who were more interested in rethinking these programs and concerned about the long-term trajectory of the federal deficit. Trump has historically not been one of them. What Trump meant exactly, I think, is sort of TBD, but I think it does provide this opening. I’m sure that we’ll see Biden talking about this a lot more as the campaign wears on and it wouldn’t surprise me at all to see this clip in television ads and featured again and again.

Kenen: So it’s both, I mean, it’s basically, he’s talked about reopening the repeal fight as Julie just mentioned, which did not go too well for the Republicans last time, and there’s plenty to cut in Medicare. If you read the whole quote, he does then talk about fraud and abuse and mismanagement, but the soundbite is the soundbite. Those are the words that came out of his mouth, whether he meant it that way or not, and we will see that campaign ad a lot, some version of it.

Rovner: My theory is that he was, and this is something that Trump does, he was on CNBC, he knew he was talking to a business audience, and he liked to say what he thinks the audience wants to hear without — you would think by now he would know that speaking to one audience doesn’t mean that you’re only speaking to that one audience. I think that’s why he’s all over the place on a lot of issues because he tends to tailor his remarks to what he thinks the people he is speaking directly to want to hear. But meanwhile, Anna, as you mentioned, he’s also raised the specter of the Affordable Care Act repeal again.

Sanger-Katz: I do think the juxtaposition of the Biden budget and State of the Union and these remarks from Trump, who now is officially the presumptive nominee for president, I think it really does highlight that there are pretty high stakes in health care for this election. I think it’s not been a focus of our discussion of this election so far. But Julie, you’ve mentioned the expiration of these subsidies that have made Affordable Care Act plans substantially more affordable for Americans and substantially more appealing, nearly doubling the number of people who are enrolled in these plans.

That is a policy that is going to expire at the end of next year. And so you could imagine a scenario, even if Trump did not want to repeal the Affordable Care Act, which he does occasionally continue to make noises about, where that could just go away through pure inertia if you didn’t have an administration that was actively trying to extend that policy and you could see a real retrenchment: increases in prices, people leaving the market, potentially some instability in the marketplace itself, where you might see insurers exiting or other kinds of problems and a situation much more akin to what we saw in the Trump administration where those markets were “OK, but were a little bit rocky and not that popular.”

I think similarly for Medicare and Medicaid, these big federal health programs, Biden has really been committed to, as he says, not cutting them. The Medicare price negotiation for drugs has provided a little bit more savings for the program. So it’s on a little bit of a better fiscal trajectory, and he has these additional proposals, again, I think long shots politically to try to shore up Medicare’s finances more. So you see this commitment to these programs and certainly this commitment to — there were multiple things in the budget to try to liberalize and expand Medicaid coverage to make postpartum coverage for women after they give birth, permanently one year after birth, people would have coverage.

Right now, that’s an option for states, but it’s not required for every state. And additionally to try to, in an optional basis, make it a little easier to keep kids enrolled in Medicaid for longer, to just allow states to keep kids in for the first six years of life and then three years at a time after that. So again, that’s an option, but I think you see the Biden administration making a commitment to expand and shore up these programs, and I do think a Trump administration and a Republican Congress might be coming at these programs with a bit more of a scalpel.

Rovner: And also, I mean, one of the things we haven’t talked about very much since we’re on the subject of the campaign is that this year Trump is ready in a way that he was not, certainly not in 2016 and not even in 2020. He’s got the Heritage Foundation behind him with this whole 2025 blueprint, people with actual expertise in knowing what to turn, what to do, actually, how to manipulate the bureaucracy in a way that the first Trump administration didn’t have to. So I think we could see, in fact, a lot more on health care that Republicans writ large would like to do if Trump is reelected. Joanne, you wanted to add something.

Kenen: Yeah, I mean, we all didn’t see this year as a health care election, and I still think that larger existential issues about democracy, it’s a reprise. It’s 2020 all over again in many ways, but abortion yes, abortion is a health care issue, and that was still going …

Rovner: We’re getting to that next.

Kenen: I know, but I mean we all knew that was still going to be a ballot driver, a voter driver. But Trump, with two remarks, however, well, there’s a difference between the people at the Heritage Foundation writing detailed policy plans about how they’re going to dismantle the CDC [Centers for Disease Control and Prevention] as we currently know it versus what Trump says off the cuff. I mean, if you say to a normal person on the street, we want to divide the CDC in two, that’s not going to trigger anything for a voter. But when you start talking about we want to take away your health care subsidies and cut Medicare, so these are sort of, some observers have called them unforced errors, but basically right now, yeah, we’re in another health care election. Not the top issue — and also depending on what else goes on in the world, because it’s a pretty shaky place at the moment. By September, will it be a top three issue? None of us know, but right now it’s more of a health care election than it was shaping up to be even just a few weeks ago.

Rovner: Yeah. Well, one thing, as you said, that we all know will be a big campaign issue this fall is abortion. We saw that in the State of the Union with the gallery full of women who’d been denied abortion, IVF services, and other forms of reproductive health care and the dozens of Democratic women on the floor of the House wearing white from head to toe as a statement of support for reproductive health care. While Democrats do have some divides over how strongly to embrace abortion rights, a big one is whether restoring Roe [v. Wade] is enough or they need to go even further in assuring access to basically all manner of reproductive health care.

It’s actually the Republicans who are most on the defensive, particularly over IVF and other state efforts that would restrict birth control by declaring personhood from the moment of fertilization. Along those lines, one of the more interesting stories I saw this week suggested that Donald Trump, who has fretted aloud about how unpopular the anti-abortion position is among the public, seems less likely to choose a strong pro-lifer as his running mate this time. Remember Mike Pence came along with that big anti-abortion background. What would this mean? It’s not like he’s going to choose Susan Collins or Lisa Murkowski or some Republican that we know actually supports abortion rights. I’m not sure I see what this could do for him and who might fit this category.

Kenen: Well, I think there’s a good chance he’ll choose a woman, and we all have names at the tip of our tongues, but we don’t know yet. But yeah, I mean they need to soften some of this stuff. But Trump’s own attempt right now bragging about appointing the justices that killed Roe, at the same time, he’s apparently talking about a 15-week ban or a 16-week ban, which is very different than zero. So he’s giving a mixed message. That’s not what his base wants to hear from him, obviously. I mean, Julie, you’ll probably get to this, but the IVF thing is also pitting anti-abortion Republican against anti-abortion Republican, with Mike Pence, again, being a very good example where Mike Pence’s anti-abortion bona fides are pretty clear, but he has been public about his kids are IVF babies? I’m not sure if all of them are, but at least some of them are. So he does not think that two cells in a freezer or eight cells or 16 cells is the same to child. In his view, it’s a potential child. So yeah.

Edney: I think you can do a lot with a vice president. We see Biden has his own issues with the abortion issue and, as people have pointed out, he demurred from saying that word in the State of the Union and we see just it was recently announced that Vice President Kamala Harris is going to visit an abortion clinic. So you can appease maybe the other side, and that might be what Trump is looking to do. I think, as Joanne mentioned, his base wants him to be anti-abortion, but now you’re getting all of these fractures in the Republican Party and you need someone that maybe can massage that and help with the crowd that’s been voting on the state level, voting on more of a personal level, to keep reproductive rights, even though his base doesn’t seem to be that that’s what they want. So I feel like he may be looking to choose someone who’s very different or has some differences that he can, not acknowledge, but that they can go out and please the other side.

Rovner: Of course, the only person who really fits that bill is Nikki Haley, who is very, very strongly anti-abortion, but at least tried, not very well, but tried to say that there are other people around and they believe other things and we should embrace them, too. I can’t think of another Republican except for Nikki Haley who’s really tried to do that. Margot, you wanted to say something?

Sanger-Katz: Oh, I was just going to say that if this reporting is correct, I think it does really reflect the political moment that Trump finds himself in. I think when he was running the last time, I think he really had to convince the anti-abortion voter, the evangelical voter, to come along with him. I think they had reservations about his character, about his commitment to their cause. He was seen as someone who maybe wasn’t really a true believer in these issues. And so I think he had to do these things, like choosing Mike Pence, choosing someone who was one of them. Pre-publishing a list of judges that he would consider for the Supreme Court who were seen as rock solid on abortion. He had to convince these voters that he was the real deal and that he was going to be on their side, and I just don’t think he really has that problem to the same degree right now.

I think he’s consolidated support among that segment of the electorate and his bigger concern going into the general election, and also the primaries are over, and so his bigger concern going into the general election is how to deal with more moderate swing voters, suburban women, and other groups who I think are a little bit concerned about the extreme anti-abortion policies that have been pursued in some of these states. And I think they might be reluctant to vote for Trump if they see him as being associated with those policies. So you see him maybe thinking about how to soften his image on this issue.

Rovner: I should point out the primaries aren’t actually over, most of states still haven’t had their primaries, but the primaries are effectively over for president because both candidates have now amassed enough delegates to have the nomination.

Sanger-Katz: Yes, that’s right. And it’s not over until the convention, although I think the way that the Republicans have arranged their convention, it’s very hard to imagine anyone other than Trump being president no matter what happens.

Rovner: Yes.

Sanger-Katz: Or not being president. Sorry, being the nominee.

Rovner: Being the nominee, yes, indeed. Well, we are only two weeks away from the Supreme Court oral arguments in the abortion pill case and a little over a month from another set of Supreme Court oral arguments surrounding whether doctors have to provide abortions in medical emergencies. And the cases just keep on coming in court this week. A three-judge panel from the 5th Circuit Court of Appeals upheld in part a lower court ruling that held that Texas’ law requiring parents to provide consent before their teenage daughters may obtain prescription birth control, Trump’s federal rules requiring patient confidentiality even for minors at federally funded Title X clinics.

Two things about this case. First, it’s a fight that goes all the way back to the Reagan administration and something called the “Squeal Rule,” which I did not cover, I only read about, but it’s something that the courts have repeatedly ruled against, that Title X is in fact allowed to maintain patient privacy even for teenagers. And the second thing is that the lower court ruling came from Texas federal Judge Matthew Kacsmaryk, who also wrote the decision attempting to overturn the FDA’s approval of the abortion drug mifepristone. This one, though, we might not expect to get to the Supreme Court.

Kenen: But we’re often wrong on these kinds of things.

Rovner: Yeah, that’s true.

Kenen: I mean, things that seem based on the historical pathway that shouldn’t have gotten to the court are getting to the court and the whole debate has shifted so far to the right. An interesting aside, there is a move, and I read this yesterday, but now I’m forgetting the details, so one of you can clarify for me. I can’t remember whether they’re considering doing this or the way they’ve actually put into place steps to prevent judge-shopping.

Rovner: That’s next.

Kenen: OK, I’m sorry, I’m doing such a good job of reading your mind.

Rovner: You are such a good job, Joanne.

Kenen: But I mean so many in these cases go back to one. If there was a bingo card for reproductive lawsuits, there might be one face in it.

Rovner: Two, Judge [Reed] O’Connor, remember the guy with the Affordable Care Act.

Kenen: Right. But so much of this is going back to judge-shopping or district-shopping for the judge. So a lot of these things that we thought wouldn’t get to the court have gotten to the court.

Rovner: Yeah, well, no, I was going to say in this case, though, there seems to be some suggestion that those who support the confidentiality and the Title X rules might not want to appeal this to the Supreme Court because they’re afraid they’ll lose. That this is the Supreme Court that overturned Roe, it would almost certainly be a Supreme Court that would rule against Title X confidentiality for birth control, that perhaps they want to just let this lie. I think as it stands now it only applies to the 5th Circuit. So Texas, Louisiana, and I forget what else is in the 5th Circuit, but it wouldn’t apply around the country and in this case, I guess it’s just Texas because it’s Texas’ law that conflicts with the rules.

Kenen: Except when one state does something, it doesn’t mean that it’s only Texas’ law six months from now.

Rovner: Right. What starts in Texas doesn’t necessarily stay in Texas.

Kenen: Right, it could go to Nevada. They may decide that they have a losing case and they want to wait 20 years, but other people end up taking things — I mean, it is very unpredictable and a huge amount of the docket is reproductive health right now.

Rovner: I would say the one thing we know is that Justice Alito, when he said that the Supreme Court was going to stop having to deal with this issue was either disingenuous or just very wrong because that is certainly not what’s happened. Well, as Joanne already jumped ahead a little bit, I mentioned Judge Kacsmaryk for a specific reason. Also this week, the Judicial Conference of the United States, which makes rules for how the federal courts work, voted to make it harder to judge-shop by filing cases in specific places like Amarillo, Texas, where there’s only one sitting federal judge. This is why Judge Kacsmaryk has gotten so many of those hot-button cases. Not because kookie stuff happens all the time in Amarillo, but because plaintiffs have specifically filed suit there to get their cases in front of him. The change by the judicial conference basically sets things back to the way they used to be, right, where it was at least partly random, which judge you got when you filed a case.

Kenen: But there are also some organizations that have intentionally based themselves in Amarillo so that they’re there. I mean, we may also see, if the rules go back to the old days, we may also still say you have a better case for filing in where you actually operate. So everybody just keeps hopping around and playing the field to their advantage.

Rovner: Yeah. And I imagine in some places there’s only a couple of judges, I think it was mostly Texas that had these one-judge districts where you knew if you filed there, you were going to get that judge, so — the people who watch these things and who worry about judge-shopping seem to be heartened by this decision by the judicial conference. So I’m not someone who is an expert in that sort of thing, but they seem to think that this will deter it, if not stop it entirely.

Moving on, remember a couple of weeks ago when I said that the hack of UnitedHealth [Group] subsidiary Change Healthcare was the most undercovered story in health? Clearly, I had no idea how true that was going to become. That processes 15 billion — with a B — claims every year handles one of every three patient records is still down, meaning hospitals, doctor’s offices, nursing homes, and all other manner of health providers still mostly aren’t getting paid. Some are worrying they soon won’t be able to pay their employees. How big could this whole mess ultimately become? I don’t think anybody anticipated it would be as big as it already is.

Sanger-Katz: I think it’s affecting a number of federal programs, too, that rely on this data, like quality measurement. And it really is a reflection, first of all, obviously of the consolidation of all of this, which I know that you guys have talked about on the podcast before, but also just the digitization and interconnectedness of everything. All of these programs are relying on this billing information, and we use that not just to pay people, but also to evaluate what kind of health care is being delivered, and what quality it is, and how much we should pay people in Medicare Advantage, and on all kinds of other things. So it’s this really complex, interconnected web of information that has been disrupted by this hack, and I think there’s going to be quite a lot of fallout.

Edney: And the coverage that I’ve read we’re potentially, and not in an alarmist way, but weeks away from maybe some patients not getting care because of this, particularly at the small providers. Some of my colleagues did a story yesterday on the small cancer providers who are really struggling and aren’t sure how long they’re going to be able to keep the lights on because they just aren’t getting paid. And there are programs now that have been set up but maybe aren’t offering enough money in these no-interest loans and things like that. So it seems like a really precarious situation for a lot of them. And now we see that HHS [Department of Health and Human Services] is looking into this other side of it. They’re going to investigate whether there were some HIPAA violations. So not looking exactly at the money exchange, but what happened in this hack, which is interesting because I haven’t seen a lot about that, and I did wonder, “Oh, what happened with these patients’ information that was stolen?” And UnitedHealth has taken a huge hit. I mean, it’s a huge company and it’s just taken a huge hit to its reputation and I think …

Rovner: And to its stock price.

Edney: And it’s stock price. That is very true. And they don’t know when they’re actually going to be able to resolve all of this. I mean, it’s just a huge mess.

Rovner: And not to forget they paid $22 million in ransom two weeks ago. When I saw that, I assumed that this was going to be almost over because usually I know when a hospital gets hacked, everybody says, don’t pay ransom, but they pay the ransom, they get their material back, they unlock what was locked away. And often that ends it, although it then encourages other people to do it because hey, if you do it, you can get paid ransom. Frankly, for UnitedHealthcare, I thought $22 million was a fairly low sum, but it does not appear — I think this has become such a mess that they’re going to have to rebuild the entire operation in order to make it work. At least, not a computer expert here. But that’s the way I understand this is going on.

Kenen: But I also think this, I mean none of us are cyber experts, but I’m also wondering if this is going to lead to some kind of rethinking about alternative ways of paying people. If this created such chaos, and not just chaos, damage, real damage, the incentive to do something similar to another, intermediate, even if it’s not quite this big. It’s like, “Wait, no one wants to be the next one.” So what kind of push is there going to be, not just for greater cybersecurity, but for Plan B when there is a crisis? And I don’t know if that’s something that the cyberexperts can put together in what kind of timeline — if HHS was to require that or whether the industry just decides they need it without requirements that this is not OK. It’s going to keep happening if it’s profitable for whoever’s doing it.

Rovner: I remember, ruefully, Joanne and I were there together covering HIPAA when they were passing it, which of course had nothing whatsoever to do with medical privacy at the time, but what it did do was give that first big push to start digitizing medical information. And there was all this talk about how wonderful it was going to be when we had all this digitally and researchers could do so much with it, and patients would be able to have all of their records in one place and …

Kenen: You get to have 19 passwords for 19 different forums now.

Rovner: Yes. But in 1995 it all seemed like a great, wonderful new world of everything being way more efficient. And I don’t remember ever hearing somebody talking about hacking this information, although as I point out the part of HIPAA that we all know, the patient medical records privacy, was added on literally at the last minute because someone said, “Uh-oh, if we’re going to digitize all this information, maybe we better be sure that it doesn’t fall into the wrong hands.” So at least somebody had some idea that we could be here. What are we 20, 30 … are we 30 years later? It’s been a long time. Anyway, that’s my two cents. All right, next up, Mississippi is flirting with actually expanding Medicaid under the Affordable Care Act. It’s one of only 10 remaining states that has not extended the program to people who have very low incomes but don’t meet the so-called categorical eligibility requirements like being a pregnant woman or child or person with a disability.

The Mississippi House passed an expansion bill including a fairly stringent work requirement by a veto-proof majority last week, week before.

Kenen: I think two weeks ago.

Rovner: But even if it passed the Senate and gets signed by the governor, which is still a pretty big if, the governor is reportedly lobbying hard against it. The plan would require a waiver from the Biden administration, which is not a big fan of work requirements. On the other hand, even if it doesn’t happen, and I would probably put my money at this point that it’s not going to happen this year, does it signal that some of the most strident, holdout states might be seeing the attraction of a 90% federal match and some of the pleas of their hospital associations? Anna, I see you nodding.

Edney: Yeah, I mean it was a little surprising, but this is also why I love statehouses. They just do these unexpected things that maybe make sense for their constituents sometimes, and it’s not all the time. I thought that it seemed like they had come around to the fact that this is a lot of money for Mississippi and it can help a lot of people. I think I’ve seen numbers like maybe adding 200,000 or so to the rolls, and so that’s a huge boost for people living there. And with the work requirement, is it true that even if the Biden administration rejects it, this plan can still go into place, right?

Kenen: The House version.

Edney: The House version.

Kenen: Yes.

Edney: Yeah.

Rovner: My guess is that’s why the governor is lobbying so hard against it. But yeah.

Kenen: I mean, I think that we had been watching a couple of states, we keep hearing Alabama was one of the states that has been talking about it but not doing anything about it. Wyoming, which surprised me when they had a little spurt of activity, which I think has subsided. I mean, what we’ve been saying ever since the Supreme Court made this optional for states more than 10 years ago now. Was it 2012? We’ve been saying eventually they’ll all do it. Keeping in mind that original Medicaid in [19]65, it took until 1982, which neither Julie nor I covered, until the last state, which was Arizona, took regular Medicare, Medicaid, the big — forget the ACA stuff. I mean, Medicaid was not in all states for almost 20 years. So I think we’ve all said eventually they’re going to do it. I don’t think that we are about to see a domino effect that North Carolina, which is a purple state, they did it a few months ago, maybe a year by now.

There was talk then that, “Oh, all the rest will do it.” No, all the rest will probably do it eventually, but not tomorrow. Mississippi is one of the poorest states in the country. It has one of the lowest health statuses of their population, obesity, diabetes, other chronic diseases. It has a very small Medicaid program. The eligibility levels are even for very, very, very poor childless adults, you can’t get on their plan. But have we heard rural hospitals pushing for this for a decade? Yes. Have we heard chambers of commerce in some of these states wanting it because communities without hospitals or communities without robust health systems are not economically attractive? We’ve been hearing the business community push for this for a long time. But the holdouts are still holdouts and I do think they will all take it. I don’t think it’s imminent.

Rovner: Yeah, I think that’s probably a fair assessment.

Kenen: It makes good economic sense, I mean, you’re getting all this money from the federal government to cover poor people and keep your hospitals open. But it’s a political fight. It’s not just a …

Rovner: It’s ideology.

Kenen: Yes, it’s not a [inaudible]. And it’s called Obamacare.

Edney: And sometimes things just have to fall into place. Mississippi got a new speaker of the House in their state government, so that’s his decision to push this as something that the House was going to take up. So whether that happens in other places, whether all those cards fall into places can take more time.

Kenen: Well, the last thing is we also know it’s popular with voters because we’ve seen it on the ballot in what, seven states, eight states, I forgot. And it won, and it won pretty big in really conservative states like Idaho and Utah. So as Julie said, this is ideology, it’s state lawmakers, it’s governors, it’s not voters, it’s not hospitals, it’s not chambers of commerce. It’s not particularly rural hospitals. A lot of people think this makes sense, but their own governments don’t think it makes sense.

Rovner: Yes. Well, another of those stories that moves very, very slowly. Finally, “This Week in Medical Misinformation”: I want to call out those who are fighting back against those who are accusing them of spreading false or misleading claims. I know this sounds confusing. Specifically, 16 conservative state attorneys general have called on YouTube to correct a, quote, “context disclaimer” that it put on videos posted by the anti-abortion Alliance Defending Freedom claiming serious and scientifically unproven harms that can be caused by the abortion pill mifepristone.

Unfortunately, for YouTube, their context disclaimer was a little clunky and conflated medication and surgical abortion, which still doesn’t make the original ADF videos more accurate, just means that the disclaimer wasn’t quite right. Meanwhile, more anti-abortion states are having legal rather than medical experts try to “explain” — and I put explain in air quotes — when an abortion to save the life of a woman is or isn’t legal, which isn’t really helping clarify the situation much if you are a doctor worried about having your license pulled or, at best, ending up having to defend yourself in court. It feels like misinformation is now being used as a weapon as well as a way to mislead people. Or am I reading this wrong?

Edney: I mean, I had to read that disclaimer a few times. Just the whole back-and-forth was confusing enough. And so it does feel like we’re getting into this new era of, if you say one wrong thing against the disinformation, that’s going to be used against you. So everybody has to be really careful. And the disclaimer, it was odd because I thought it said the procedure is [inaudible]. So that made me think, oh, they’re just talking about the actual surgical abortion. But it was clunky. I think clunky is a good word that you used for it. So yeah.

Rovner: Yeah, it worries me. I think I see all of this — people who want to put out misinformation. I’m not accusing ADF of saying, “We’re going to put out misinformation.” I think this is what they’ve been saying all along, but people who do want to put out misinformation for misinformation’s sake are then going to hit back at the people who point out that it’s misinformation, which of course there’s no way for the public to then know who the heck is right. And it undercuts the idea of trying to point out some of this misinformation. People ask me wherever I go, “What are we going to do about this misinformation?” My answer is, “I don’t know, but I hope somebody thinks of something.”

Kenen: I mean, if you word something poorly, you got to fix it. I mean, that’s just the bottom line. Just like we as journalists have to come clean when we make a mistake. And it feels bad to have to write a correction, but we do it. So Google has been working on — there’s a group convened by the Institute of Medicine [National Academy of Medicine] and the World Health Organization and some others that have come out with guidelines and credible communicators, like who can you trust? I mean, we talked about the RSV [respiratory syncytial virus] story I did a few weeks ago, and if you Google RSV vaccine on and you look on YouTube or Google, it’s not that there’s zero misinformation, but there’s a lot less than there used to be. And what comes up first is the reliable stuff: CDC, Mayo Clinic, things like that. So YouTube has been really working on weeding out the disinformation, but again, for their own credibility, if they want to be seen as clean arbiters of going with credibility, if they get something mushy, they’ve got to de-mush it at the end.

Rovner: And I will say that Twitter of all places — or X, whatever you want to call it, the place that everybody now is like, “Don’t go there. It’s just a mess” — has these community notes that get attached to some of the posts that I actually find fairly helpful and it lets you rate it.

Kenen: Some of them, I mean overall, there’s actually research on that. We’ll talk about my book when it comes out next year, but we have stuff. I’m in the final stages of co-authoring a book that … it goes into misinformation, which is why I’ve learned a lot about this. Community Notes has been really uneven and …

Rovner: I guess when it pops up in my feed, I have found it surprisingly helpful and I thought, “This is not what I expect to see on this site.”

Kenen: And it hasn’t stopped [Elon] Musk himself from tweeting misinformation about drugs …

Rovner: That’s certainly true.

Kenen: … drugs he doesn’t like, including the birth control pill he tells people not to use because it promotes suicide. So basically, yeah, Julie, you’re right that we need tools to fight it, and none of the tools we currently have are particularly effective yet. And absolutely everything gets politicized.

Sanger-Katz: And it’s a real challenge I think for these social media platforms. You know what I mean? They don’t really want to be in the editorial business. I think they don’t really want to be in the moderation business in large part. And so you can see them grappling with the problem of the most egregious forms of misinformation on their platforms, but doing it clumsily and anxiously and maybe making mistakes along the way. I think it’s not a natural function for these companies, and I think it’s not a comfortable function for the people that run these companies, who I think are much more committed to free discourse and algorithmic sharing of information and trying to boost engagement as opposed to trying to operate the way a newspaper editor might be in selecting the most useful and true information and foregrounding that.

Kenen: Yeah, I mean that’s what the Supreme Court has been grappling with too, is another [inaudible] … what are the rules of the game? What should be legally enforced? What is their responsibility, that the social media company’s responsibilities, to moderate versus what is just people get to post? I mean, Google’s trying to use algorithms to promote credible communicators. It’s not that nothing wrong is there, but it’s not what you see first.

Rovner: I think it’s definitely the issue of the 2020s. It is not going away anytime soon.

Kenen: And it’s not just about health.

Rovner: Oh, absolutely. I know. Well, that is the news for this week. Now, we will play my interview with Dr. Kelly Henning of Bloomberg Philanthropies, and then we’ll come back with our extra credits.

I am so pleased to welcome to the podcast Dr. Kelly Henning, who heads the Bloomberg Philanthropies Public Health program. She’s here to tell us about a new documentary series about the past, present, and future of public health called “The Invisible Shield.” It premieres on PBS on March 26. Dr. Henning, thank you so much for joining us.

Kelly Henning: Thank you for having me.

Rovner: So the tagline for this series is, “Public health saved your life today, and you don’t even know it.” You’ve worked in public health in a lot of capacities for a lot of years, so have I. Why has public health been so invisible for most of the time?

Henning: It’s a really interesting phenomenon, and I think, Julie, we all take public health for granted on some level. It is what really protects people across the country and across the world, but it is quite invisible. So usually if things are working really well in public health, you don’t think about it at all. Things like excellent vaccination programs, clean water, clean air, these are all public health programs. But I think most people don’t really give them a lot of thought every day.

Rovner: Until we need them, and then they get completely controversial.

Henning: So to that point, covid-19 and the recent pandemic really was a moment when public health was in the spotlight very much no longer behind an invisible shield, but quite out in front. And so this seemed like a moment when we really wanted to unpack a little bit more around public health and talk about how it works, why it’s so important, and what some of the opportunities are to continue to support it.

Rovner: I feel like even before the pandemic, though, the perceptions of public health were changing. I guess it had something to do with a general anti-science, anti-authority rising trend. Were there warning signs that public health was about to explode in people’s consciousness in not necessarily a good way?

Henning: Well, I think those are all good points, but I also think that there are young generations of students who have become very interested in public health. It’s one of the leading undergraduate majors nowadays. Johns Hopkins Bloomberg School of Public Health has more applications than ever before, and that was occurring before the pandemic and even more so throughout. So I think it’s a bit of a mixed situation. I do think public health in the United States has had some really difficult times in terms of life expectancy. So we started to see declines in life expectancy way back in 2017. So we have had challenges on the program side, but I think this film is an opportunity for us to talk more deeply about public health.

Rovner: Remind people what are some of the things that public health has brought us besides, we talk about vaccines and clean water and clean air, but there’s a lot more to public health than the big headlines.

Henning: Yeah, I mean, for example, seat belts. Every day we get into our vehicle, we put a seat belt on, but I think most people don’t realize that was initially extremely controversial and actually not so easy to get that policy in place. And yet it saved literally tens of hundreds of thousands of lives across the U.S. and now across the world. So seat belts are something that often come to mind. Similar to that are things like child restraints, what we would call car seats in the U.S. That’s another similar strategy that’s been very much promoted and the evidence has been created through public health initiatives. There are other things like window guards. In cities, there are window guards that help children not fall out of windows from high buildings. Again, those are public health initiatives that many people are quite unaware of.

Rovner: How can this documentary help change the perception of public health? Right now I think when people think of public health, they think of people fighting over mask mandates and people fighting over covid vaccines.

Henning: Yeah, I really hope that this documentary will give people some perspective around all the ways in which public health has been working behind the scenes over decades. Also, I hope that this documentary will allow the public to see some of those workers and what they face, those public health front-line workers. And those are not just physicians, but scientists, activists, reformers, engineers, government officials, all kinds of people from all disciplines working in public health. It’s a moment to shine a light on that. And then lastly, I hope it’s hopeful. I hope it shows us that there are opportunities still to come in the space of public health and many, many more things we can do together.

Rovner: Longtime listeners to the podcast will know that I’ve been exploring the question of why it has been so difficult to communicate the benefits of public health to the public, as I’ve talked to lots of people, including experts in messaging and communication. What is your solution for how we can better communicate to the public all of the things that public health has done for them?

Henning: Well, Julie, I don’t have one solution, but I do think that public health has to take this issue of communication more seriously. So we have to really develop strategies and meet people where they are, make sure that we are bringing those messages to communities, and the messengers are people that the community feels are trustworthy and that are really appropriate spokespeople for them. I also think that this issue of communications is evolving. People are getting their information in different ways, so public health has to move with the times and be prepared for that. And lastly, I think this “Invisible Shield” documentary is an opportunity for people to hear and learn and understand more about the history of public health and where it’s going.

Rovner: Dr. Kelly Henning, thank you so much for joining us. I really look forward to watching the entire series. OK, we are back. It’s time for our extra-credit segment. That’s when we each recommend a story we read this week we think you should read, too. As always, don’t worry if you miss it. We will post the links on the podcast page at kffhealthnews.org and in our show notes on your phone or other mobile device. Joanne, you have everybody’s favorite story this week. Why don’t you go first?

Kenen: I demanded the right to do this one, and it’s Olga, I think her last name is pronounced Khazan. I actually know her and I don’t know how to pronounce her name, but Olga Khazan, apologies if I’ve got it wrong, from The Atlantic, has a story that says “Frigid Offices Might Be Killing Women’s Productivity.” Well, from all of us who are cold, I’m not sure I would want to use the word “frigid,” but of all of us who are cold in the office and sitting there with blankets. I used to have a contraband, very small space heater hidden behind a trash basket under my desk. We freeze because men like colder temperatures and they’re wearing suits. So we’ve been complaining about being cold, but there’s actually a study now that shows that it actually hurts our actual cognitive performance. And this is one study, there’s more to come, but it may also be one explanation for why high school girls do worse than high school boys on math SATs.

Rovner: Did not read that part.

Kenen: It’s not just comfort in the battle over the thermostat, it’s actually how do our brains function and can we do our best if we’re really cold?

Rovner: True. Anna.

Edney: This is a departure from my normal doom and gloom. So I’m happy to say this is in Scientific American, “How Hospitals Are Going Green Under Biden’s Climate Legislation.” I thought it was interesting. Apparently if you’re a not-for-profit, there were tax credits that you were not able to use, but the Inflation Reduction Act changed that so that there are some hospitals, and they talked to this Valley Children’s in California, that there had been rolling blackouts after some fires and things like that, and they wanted to put in a micro-grid and a solar farm. And so they’ve been able to do that.

And health care contributes a decent amount. I think it’s like 8.5% of U.S. greenhouse gas emissions. And Biden had established this Office of Climate Change [and Health Equity] a few years ago and within the health department. So this is something that they’re trying to do to battle those things. And I thought that it was just interesting that we’re talking about this on the day that the top story, Margot, in The New York Times is, not by you, but is about how there’s this huge surge in energy demand. And so this is a way people are trying to do it on their own and not be so reliant on that overpowered grid.

Rovner: KFF Health News has done a bunch of stories about contribution to climate change from the health sector, which I had no idea, but it’s big. Margot.

Sanger-Katz: I wanted to highlight the second story in this Lev Facher series on treatment for opioid addiction in Stat called “Rigid Rules at Methadone Clinics Are Jeopardizing Patients’ Path to Recovery From Opioid Addiction,” which is a nice long title that tells you a lot about what is in the story. But I think methadone treatment is a really evidence-based treatment that can be really helpful for a lot of people who have opioid addiction. And I think what this story highlights is that the mechanics of how a lot of these programs work are really hard. They’re punitive, they’re difficult to navigate, they make it really hard for people to have normal lives while they’re undergoing methadone treatment and then, in some cases, arbitrarily so. And so I think it just points out that there are opportunities to potentially do this better in a way that better supports recovery and it supports the lives of people who are in recovery.

Rovner: Yeah, it used the phrase “liquid handcuffs,” which I had not seen before, which was pretty vivid. For those of you who weren’t listening, the Part One of this series was an extra credit last week, so I’ll post links to both of them. My story’s from our friend Dan Diamond at The Washington Post. It’s called “Navy Demoted Ronnie Jackson After Probe Into White House Behavior.” Ronnie Jackson, in case you don’t remember, was the White House physician under Presidents [Barack] Obama and Trump and a 2021 inspector general’s report found, and I’m reading from the story here, quote, “that Jackson berated subordinates in the White House medical unit, made sexual and denigrating statements about a female subordinate, consumed alcohol inappropriately with subordinates, and consumed the sleep drug Ambien while on duty as the president’s physician.” In response to the report, the Navy demoted Jackson retroactively — he’s retired —from a rear admiral down to a captain.

Now, why is any of this important? Well, mainly because Jackson is now a member of Congress and because he still incorrectly refers to himself as a retired admiral. It’s a pretty vivid story, you should really read it.

OK. That is our show. As always, if you enjoy the podcast, you can subscribe wherever you get your podcasts. We’d appreciate it if you left us a review; that helps other people find us, too. Special thanks as always to our technical guru, Francis Ying, and our editor, Emmarie Huetteman. As always, you can email us your comments or questions. We’re at whatthehealth@kff.org, or you can still find me at X, @jrovner. Margot, where are you these days?

Sanger-Katz: I’m at all the places @Sanger-Katz, although not particularly active on any of them.

Rovner: Anna.

Edney: On X, it’s @annaedney and on Threads it’s @anna_edneyreports.

Rovner: Joanne.

Kenen: I’m Threads @joannekenen1, and I’ve been using LinkedIn more. I think some of the other panelists have said that people are beginning to treat that as a place to post, and I think many of us are seeing a little bit more traction there.

Rovner: Great. Well, we will be back in your feed next week. Until then, be healthy.

Credits

Francis Ying
Audio producer

Emmarie Huetteman
Editor

To hear all our podcasts, click here.

And subscribe to KFF Health News’ “What the Health?” on SpotifyApple PodcastsPocket Casts, or wherever you listen to podcasts.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 1 month ago

Elections, Health Industry, Insurance, Medicaid, Medicare, Multimedia, Pharmaceuticals, Public Health, States, Abortion, Biden Administration, Contraception, Drug Costs, Health IT, KFF Health News' 'What The Health?', Misinformation, Podcasts, Pregnancy, Women's Health

PAHO/WHO | Pan American Health Organization

OPS y países de las Américas buscan establecer una comisión intersectorial contra la influenza zoonótica

PAHO and countries of the Americas seek to establish an intersectoral commission to prevent and control avian influenza

Cristina Mitchell

14 Mar 2024

PAHO and countries of the Americas seek to establish an intersectoral commission to prevent and control avian influenza

Cristina Mitchell

14 Mar 2024

1 year 1 month ago

Health – Dominican Today

Médico Express and Barnaclinic sign interinstitutional agreement

Santo Domingo, March 2024.- With the aim of promoting best practices, specialized medical care and transfer of knowledge, Médico Express San Isidro and Barnaclinic signed an interinstitutional agreement.

The agreement between both parties includes teaching and care programs linked to outpatient surgery, gastroenterology, preventive medicine, telemedicine, remote second opinions, nursing care and hospital management.

The agreement was signed by Dr. Alejandro Cambiaso, executive president of Médico Express and Carles Loran Constans, manager of Barna Clínic.

Médico Express San Isidro, is the first center in a network characterized by its design and avant-garde model of preventive, diagnostic, surgical, and emergency services; promoting accessibility, quality, internationalization, and digital transformation of the Dominican health sector.

BarnaClinic encompasses a group of entities led by the “Hospital Clinic of Barcelona”, a renowned university center for biomedical care, teaching, and research, aimed at providing highly specialized and complex clinical and surgical medical services, considered one of the best centers of European assistance.

The modern outpatient center, Médico Express, will provide consultation services, surgery, an international department, adult and pediatric emergencies, a clinical laboratory, and advanced imaging studies.

About Medical Express
It is an innovative outpatient health center designed under international standards, offering high-quality medical services to the local population and tourists,  to make the best specialists, high technology, and cutting-edge treatments available to the eastern area.

1 year 1 month ago

Health

STAT

STAT+: Virtual Event: March of the Biosimilars

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Editor’s note: A recording of the event is embedded below.

Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines? Join leading experts to discuss the impact on the industry and patients.

Sponsor introduction

  • Thomas Newcomer, vice president and head of U.S. market access, Samsung Bioepis (sponsor)

Featured speakers

  • Chris M. Brown, president, McAteer
  • Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
  • Fran Gregory, MBA, PharmD, vice president of emerging therapies, Cardinal Health
  • Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)

1 year 1 month ago

Pharma, Video Chat, Biosimilars

KFF Health News

They Were Injured at the Super Bowl Parade. A Month Later, They Feel Forgotten.

KFF Health News and KCUR are following the stories of people injured during the Feb. 14 mass shooting at the Kansas City Chiefs Super Bowl celebration. Listen to how one Kansas family is coping with the trauma.

Jason Barton didn’t want to attend the Super Bowl parade this year. He told a co-worker the night before that he worried about a mass shooting. But it was Valentine’s Day, his wife is a Kansas City Chiefs superfan, and he couldn’t afford to take her to games since ticket prices soared after the team won the championship in 2020.

So Barton drove 50 miles from Osawatomie, Kansas, to downtown Kansas City, Missouri, with his wife, Bridget, her 13-year-old daughter, Gabriella, and Gabriella’s school friend. When they finally arrived home that night, they cleaned blood from Gabriella’s sneakers and found a bullet in Bridget’s backpack.

Gabriella’s legs were burned by sparks from a ricocheted bullet, Bridget was trampled while shielding Gabriella in the chaos, and Jason gave chest compressions to a man injured by gunfire. He believes it was Lyndell Mays, one of two men charged with second-degree felony murder.

“There’s never going to be a Valentine’s Day where I look back and I don’t think about it,” Gabriella said, “because that’s a day where we’re supposed to have fun and appreciate the people that we have.”

One month after the parade in which the U.S. public health crisis that is gun violence played out on live television, the Bartons are reeling from their role at its epicenter. They were just feet from 43-year-old Lisa Lopez-Galvan, who was killed. Twenty-four other people were injured. Although the Bartons aren’t included in that official victim number, they were traumatized, physically and emotionally, and pain permeates their lives: Bridget and Jason keep canceling plans to go out, opting instead to stay home together; Gabriella plans to join a boxing club instead of the dance team.

During this first month, Kansas City community leaders have weighed how to care for people caught in the bloody crossfire and how to divide more than $2 million donated to public funds for victims in the initial outpouring of grief.

The questions are far-reaching: How does a city compensate people for medical bills, recovery treatments, counseling, and lost wages? And what about those who have PTSD-like symptoms that could last years? How does a community identify and care for victims often overlooked in the first flush of reporting on a mass shooting: the injured?

The injured list could grow. Prosecutors and Kansas City police are mounting a legal case against four of the shooting suspects, and are encouraging additional victims to come forward.

“Specifically, we’re looking for individuals who suffered wounds from their trying to escape. A stampede occurred while people were trying to flee,” said Jackson County Prosecutor Jean Peters Baker. Anyone who “in the fleeing of this event that maybe fell down, you were trampled, you sprained an ankle, you broke a bone.”

Meanwhile, people who took charge of raising money and providing services to care for the injured are wrestling with who gets the money — and who doesn’t. Due to large donations from celebrities like Taylor Swift and Travis Kelce, some victims or their families will have access to hundreds of thousands of dollars for medical expenses. Other victims may simply have their counseling covered.

The overall economic cost of U.S. firearm injuries is estimated by a recent Harvard Medical School study at $557 billion annually. Most of that — 88% — represented quality-of-life losses among those injured by firearms and their families. The JAMA-published study found that each nonfatal firearm injury leads to roughly $30,000 in direct health care spending per survivor in the first year alone.

In the immediate aftermath of the shootings, as well-intentioned GoFundMe pages popped up to help victims, executives at United Way of Greater Kansas City gathered to devise a collective donation response. They came up with “three concentric circles of victims,” said Jessica Blubaugh, the United Way’s chief philanthropy officer, and launched the #KCStrong campaign.

“There were folks that were obviously directly impacted by gunfire. Then the next circle out is folks that were impacted, not necessarily by gunshots, but by physical impact. So maybe they were trampled and maybe they tore a ligament or something because they were running away,” Blubaugh said. “Then third is folks that were just adjacent and/or bystanders that have a lot of trauma from all of this.”

PTSD, Panic, and the Echo of Gunfire

Bridget Barton returned to Kansas City the day after the shooting to turn in the bullet she found in her backpack and to give a statement at police headquarters. Unbeknownst to her, Mayor Quinton Lucas and the police and fire chiefs had just finished a press conference outside the building. She was mobbed by the media assembled there — interviews that are now a blur.

“I don’t know how you guys do this every day,” she remembered telling a detective once she finally got inside.

The Bartons have been overwhelmed by well wishes from close friends and family as they navigate the trauma, almost to the point of exhaustion. Bridget took to social media to explain she wasn’t ignoring the messages, she’s just responding as she feels able — some days she can hardly look at her phone, she said.

A family friend bought new Barbie blankets for Gabriella and her friend after the ones they brought to the parade were lost or ruined. Bridget tried replacing the blankets herself at her local Walmart, but when she was bumped accidentally, it triggered a panic attack. She abandoned her cart and drove home.

“I’m trying to get my anxiety under control,” Bridget said.

That means therapy. Before the parade, she was already seeing a therapist and planning to begin eye movement desensitization and reprocessing, a form of therapy associated with treating post-traumatic stress disorder. Now the shooting is the first thing she wants to talk about in therapy.

Since Gabriella, an eighth grader, has returned to middle school, she has dealt with the compounding immaturity of adolescence: peers telling her to get over it, pointing finger guns at her, or even saying it should have been her who was shot. But her friends are checking on her and asking how she’s doing. She wishes more people would do the same for her friend, who took off running when the shooting started and avoided injury. Gabriella feels guilty about bringing her to what turned into a horrifying experience.

“We can tell her all day long, ‘It wasn’t your fault. She’s not your responsibility.’ Just like I can tell myself, ‘It wasn’t my fault or my responsibility,’” Bridget said. “But I still bawled on her mom’s shoulder telling her how sorry I was that I grabbed my kid first.”

The two girls have spent a lot of time talking since the shooting, which Gabriella said helps with her own stress. So does spending time with her dog and her lizard, putting on makeup, and listening to music — Tech N9ne’s performance was a highlight of the Super Bowl celebration for her.

In addition to the spark burns on Gabriella’s legs, when she fell to the concrete in the pandemonium she split open a burn wound on her stomach previously caused by a styling iron.

“When I see that, I just picture my mom trying to protect me and seeing everyone run,” Gabriella said of the wound.

It’s hard not to feel forgotten by the public, Bridget said. The shooting, especially its survivors, have largely faded from the headlines aside from court dates. Two additional high-profile shootings have occurred in the area since the parade. Doesn’t the community care, she wonders, that her family is still living with the fallout every day?

“I’m going to put this as plainly as possible. I’m f—ing pissed because my family went through something traumatic,” Bridget vented in a recent social media post. “I don’t really want anything other [than], ‘Your story matters, too, and we want to know how you’re doing.’ Have we gotten that? Abso-f—lutely not.”

‘What Is the Landscape of Need?’

Helped in part by celebrities like Swift and Kelce, donations for the family of Lopez-Galvan, the lone fatality, and other victims poured in immediately after the shootings. Swift and Kelce donated $100,000 each. With the help of an initial $200,000 donation from the Kansas City Chiefs, the United Way’s #KCStrong campaign took off, reaching $1 million in the first two weeks and sitting at $1.2 million now.

Six verified GoFundMe funds were established. One solely for the Lopez-Galvan family has collected over $406,000. Smaller ones were started by a local college student and Swift fans. Churches have also stepped up, and one local coalition had raised $183,000, money set aside for Lopez-Galvan’s funeral, counseling services for five victims, and other medical bills from Children’s Mercy Kansas City hospital, said Ray Jarrett, executive director of Unite KC.


Money for Victims Rolls In

Donations poured in for those injured at the Super Bowl Parade in Kansas City after the Feb. 14 shootings. The largest, starting with a $200,000 donation from the Kansas City Chiefs, is at the United Way of Greater Kansas City. Six GoFundMe sites also popped up, due in part to $100,000 donations each from Taylor Swift and Travis Kelce. Here’s a look at the totals as of March 12.United Way#KCStrong: $1.2 million.Six Verified GoFundMe AccountsLisa Lopez-Galvan GoFundMe (Taylor Swift donated): $406,142Reyes Family GoFundMe (Travis Kelce donated): $207,035Samuel Arellano GoFundMe: $11,896Emily Tavis GoFundMe: $9,518Cristian Martinez’s GoFundMe for United Way: $2,967Swifties’ GoFundMe for Children’s Mercy hospital: $1,060ChurchesResurrection (Methodist) “Victims of Violence Fund”: $53,358‘The Church Loves Kansas City’: $183,000 

Meanwhile, those leading the efforts found models in other cities. The United Way’s Blubaugh called counterparts who’d responded to their own mass shootings in Orlando, Florida; Buffalo, New York; and Newtown, Connecticut.

“The unfortunate reality is we have a cadre of communities across the country who have already faced tragedies like this,” Blubaugh said. “So there is an unfortunate protocol that is, sort of, already in place.”

#KCStrong monies could start being paid out by the end of March, Blubaugh said. Hundreds of people called the nonprofit’s 211 line, and the United Way is consulting with hospitals and law enforcement to verify victims and then offer services they may need, she said.

The range of needs is staggering — several people are still recovering at home, some are seeking counseling, and many weren’t even counted in the beginning. For instance, a plainclothes police officer was injured in the melee but is doing fine now, said Police Chief Stacey Graves.

Determining who is eligible for assistance was one of the first conversations United Way officials had when creating the fund. They prioritized three areas of focus: first were the wounded victims and their families, second was collaborating with organizations already helping victims in violence intervention and prevention and mental health services, and third were the first responders.

Specifically, the funds will be steered to cover medical bills, or lost wages for those who haven’t been able to work since the shootings, Blubaugh said. The goal is to work quickly to help people, she said, but also to spend the money in a judicious, strategic way.

“We don’t have a clear sightline of the entire landscape that we’re dealing with,” Blubaugh said. “Not only of how much money do we have to work with, but also, what is the landscape of need? And we need both of those things to be able to make those decisions.”

Firsthand Experience of Daily Kansas City Violence

Jason used his lone remaining sick day to stay home with Bridget and Gabriella. An overnight automation technician, he is the family’s primary breadwinner.

“I can’t take off work, you know?” he said. “It happened. It sucked. But it’s time to move on.”

“He’s a guy’s guy,” Bridget interjected.

On Jason’s first night back at work, the sudden sound of falling dishes startled Bridget and Gabriella, sending them into each other’s arms crying.

“It’s just those moments of flashbacks that are kicking our butts,” Bridget said.


Tell Us About Your Experience

We are continuing to report on the effects of the parade shooting on the people who were injured and the community as a whole. Do you have an experience you want to tell us about, or a question you think we should look into? Message KCUR’s text line at (816) 601-4777. Your information will not be used in an article without your permission.

In a way, the shooting has brought the family closer. They’ve been through a lot recently. Jason survived a heart attack and cancer last year. Raising a teenager is never easy.

Bridget can appreciate that the bullet lodged in her backpack, narrowly missing her, and that Gabriella’s legs were burned by sparks but she wasn’t shot.

Jason is grateful for another reason: It wasn’t a terrorist attack, as he initially feared. Instead, it fits into the type of gun violence he’d become accustomed to growing up in Kansas City, which recorded its deadliest year last year, although he’d never been this close to it before.

“This crap happens every single day,” he said. “The only difference is we were here for it.”

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

1 year 1 month ago

Health Care Costs, Public Health, States, Emergency Medicine, Guns, Investigation, Kansas, Missouri

PAHO/WHO | Pan American Health Organization

Global child deaths reach historic low in 2022 – UN report

Global child deaths reach historic low in 2022 – UN report

Cristina Mitchell

13 Mar 2024

Global child deaths reach historic low in 2022 – UN report

Cristina Mitchell

13 Mar 2024

1 year 1 month ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Centre notifies Uniform Code for Pharmaceutical Marketing Practices - UCPMP 2024 for Pharma Industry, details

New Delhi: The Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, has issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024.

The voluntary code of marketing practices for the Indian Pharmaceutical Industry- UCPMP 2024 aims to ensure transparency, integrity, and accountability in the marketing of pharmaceutical products, emphasizing ethical practices within the sector to safeguard the interests of patients and healthcare professionals.

This code governs the conduct of pharmaceutical companies in their marketing practices, duly covering various aspects such as medical representatives, textual and audio-visual promotional materials, samples, gifts, etc.

Further, the code establishes relationships with healthcare professionals, wherein the provisions related to travel facilities, hospitality and cash or monetary grants to doctors or their families have been elaborated.

The code also details the mode of operation of the code, the responsibilities of the Pharmaceutical Associations in constituting the Ethics Committee for Pharmaceutical Marketing Practices (ECPMP) for handling the complaints and the Apex Ethics Committee for Pharmaceutical Marketing Practices (AECPMP) for review, the procedure of lodging complaints, the procedure of handling of complaints by the Pharmaceutical Associations and various penalty provisions.

Salient Features of UCPMP 2024:

The code strictly prohibits the offering or providing of gifts for the personal benefit of any healthcare professional or their family members by pharmaceutical companies, agents, distributors, wholesalers, or retailers.

Further, the code imposes limitations on pecuniary benefits, stating that no financial advantages or benefits in kind may be offered, supplied, or promised to any person qualified to prescribe or supply drugs by pharmaceutical companies or their representatives.

The UCPMP 2024 restricts the provision of travel facilities, including rail, air, ship, or cruise tickets, and paid vacations to healthcare professionals or their family members, unless the individual is a speaker at an event.

“No gift should be offered or provided for personal benefit of any healthcare professional or family member (both immediate and extended) by any pharmaceutical company or its agent i.e. distributors, wholesalers, retailers, etc,” as per the UCPMP guidelines.

Similarly, hospitality such as hotel stays, expensive cuisine, or resort accommodations is prohibited unless the healthcare professional is participating as a speaker.

Cash payments or monetary grants to healthcare professionals or their family members are also prohibited under the UCPMP 2024, reinforcing the commitment to fair and ethical practices within the pharmaceutical industry.

UCPMP specifies the rules of the use of the words “safe’’ and “new’’ for drugs and stated that medical representatives must not employ any inducement or subterfuge to gain an interview and that they must not pay, under any guise, for access to a healthcare professional.

The code also bans the supply of free samples to those who are not qualified to prescribe such a product.

Besides, the companies or their representatives, or any person acting on their behalf, should not extend travel facilities inside or outside the country, including rail, air, ship, cruise tickets, paid vacations, etc. to healthcare professionals or their family members for attending conferences, seminars, workshops etc., it stated.

The promotion of a drug must be consistent with the terms of its marketing approval and a drug must not be promoted prior to receipt of its marketing approval from the competent authority, authorizing its sale or distribution, as per the code.

“Information about drugs must be balanced, up-to-date, verifiable, must not mislead either directly or by implication; accurately reflect current knowledge or responsible opinion; and must be capable of substantiation, which must be provided without delay, at request of the members of the medical and pharmacy professions, including members of other professions employed in the pharmaceutical industry,” it stated.

UCPMP further lays down the conduct for MRs in the pharma industry, “The medical representatives must at all times maintain a high standard of ethical conduct in the discharge of their duties. They must comply with all relevant requirements of the Code,” it stated.

Any violations of the code will be addressed by an Ethics Committee for Pharma Marketing Practices (ECPMP) established within each association, ensuring accountability and oversight.

The responsibility for adherence to the code rests with the Chief Executive Officer of pharmaceutical companies, who must ensure compliance with the regulations outlined in the UCPMP 2024.

Additionally, companies are required to submit self-declarations annually, detailing their adherence to the code, which will be made available on the association's website or the UCPMP portal of the Department of Pharmaceuticals.

“All associations are requested to constitute an Ethics Committee for Pharmaceutical Marketing Practices (ECPMP), set up a dedicated UCPMP portal on their website, and take further necessary steps towards implementation of this Code,” the Department of Pharmaceuticals said in the notification addressing associations of drug firms.

Uniform Code for Pharmaceuticals Marketing Practices (UCPMP) 2024General Points

As per the 'Ethical Criteria for Medicinal Drug Promotion' endorsed by the World Health Assembly in 1988, "Promotion" refers to all informational and persuasive activities by manufacturers and distributors, the effect of which is to induce the prescription, supply, purchase and/or use of medical drugs.

The promotion of a drug must be consistent with the terms of its marketing approval and a drug must not be promoted prior to receipt of its marketing approval from the competent authority, authorizing its sale or distribution.

Information about drugs must be balanced, up-to-date, verifiable, must not mislead either directly or by implication; accurately reflect current knowledge or responsible opinion; and must be capable of substantiation, which must be provided without delay, at request of the members of the medical and pharmacy professions, including members of other professions employed in the pharmaceutical industry.

Claims & Comparisons

Claims for the usefulness of a drug must be based on up-to-date evaluation of all available evidence.

The word "safe" must not be used without qualification, and it must not be stated categorically that a medicine has no side effects, toxic hazards, or risk of addiction.

The word "new" must not be used to describe any drug which has been generally available or any therapeutic intervention which has been generally promoted in India for more than a year.

Comparisons of drugs must be factual, fair, and capable of substantiation. In presenting a comparison, care must be taken to ensure that it does not mislead by distortion, by undue emphasis, by omission, or in any other similar way.

Brand names of products of other companies must not be used in comparison unless the prior consent of the companies concerned has been obtained.

Other companies, their products, services, or promotions must not be disparaged either directly or by implication.

The clinical or scientific opinions of healthcare professionals must not be disparaged either directly or by implication.

Textual and Audio-Visual Promotion

Any promotional material issued by an authorized holder, or with his authority, must be consistent with the requirements of this Code.

Where the purpose of the promotional material is to provide persons qualified to prescribe with sufficient information upon which to reach a decision for prescription or for use, the following minimum information must be given legibly and must be an integral part of the promotional material:

i. The relevant drug, the name and address of the holder of authorization for the drug (or the business name and address of the part of the business responsible for placing the drug on the market);

ii. The name of the drug, along with a list of active ingredients, using the generic name, placed immediately adjacent to the most prominent display of the name of the drug;

iii. Recommended dosage, method of use, and where not obvious, its method of administration;

iv. Adverse reactions, warnings, precautions for use and relevant contraindications for the use of the product;

v. A statement that additional information is available on request, and the date on which the above particulars were generated or last updated.

Promotional material such as mailings and journal advertisements must not be designed to disguise their real nature. Where a pharmaceutical company pays for, or otherwise secures or arranges the publication of some promotional material in journals, such promotional material must not resemble the editorial matter.

All promotional materials appearing in journals, the publication of which is paid for, or secured or arranged by a company, referring by brand name to any product of that company must comply with Clause 3.3 of this Code, irrespective of the editorial control of the material published.

Promotional material must conform, both in text and illustration, to canons of good taste and must be expressed to recognize the professional standing of the recipients and not be likely to cause offence.

The names or photographs of healthcare professionals must not be used in promotional material.

Promotional material must not imitate the devices, copy slogans or general layout used by other companies in a way that is likely to mislead or confuse.

Wherever appropriate (for example, in technical and other informative material), the date of printing, or of the last review of promotional material must be stated.

Postcards, other exposed mailings, envelopes or wrappers must not carry matter which might be regarded as advertising to the lay public, or which could be considered unsuitable for public view.

Audio-visual material must be supported by all relevant printed material so that all relevant requirements of this Code are fully complied with.

Medical Representatives

The term "medical representative" means sales representatives (including personnel retained by way of contract with third parties) and other company representatives who call on healthcare professionals, pharmacies, hospitals, or healthcare facilities in connection with promotion of drugs.

The medical representatives must at all times maintain a high standard of ethical conduct in the discharge of their duties. They must comply with all relevant requirements of the Code.

The medical representatives must not employ any inducement or subterfuge to gain an interview. They must not pay, under any guise, for access to a healthcare professional.

Companies are responsible for the activities of their employees, including the medical representatives, for ensuring compliance of this Code. This should additionally be ensured through an appropriate clause in the employment contract signed between the Company and its Medical Representatives as defined above.

Third parties working for or on behalf of the pharmaceutical companies, including those acting on their behalf (such as joint ventures and licensees), that are commissioned to engage in activities covered by this Code, should also have a sound working knowledge of this Code.

Brand Reminders

Brand Reminders are permitted in the following two categories, viz., (i) Informational and education items and (ii) Free samples provided by the companies to medical professionals.

i. Informational and educational items mean books, calendars, diaries, journals (including e-journals), dummy device models and clinical treatment guidelines for professional used in healthcare settings value of which does not exceed Rs. 1000 per item. Such items should not have an independent commercial value for the healthcare professionals.

ii. Free samples:

• Free samples of drugs shall not be supplied to any person who is not qualified to prescribe such a product.

• Where samples of products are distributed by a medical representative, the sample must be handed directly to the person qualified to prescribe such product, or to a person authorized to receive the sample on their behalf, and the name and address of the healthcare practitioner noted for records.

• The following conditions shall be observed while providing samples to a person qualified to prescribe such product:

a. Such samples are provided only for the purpose of creating awareness about treatment options and for acquiring experience in dealing with the product;

b. Sample packs should be limited to prescribed dosage for not more than three patients for the required course of treatment and no company should offer more than twelve such sample packs per drug to any healthcare practitioner per year;

c. Each sample should be marked "free medical sample not for sale" or bear another legend of analogous meaning;

d. Each sample pack should not be larger than the smallest pack present in the market;

e. An adequate system of accountability and control must be maintained in respect of supply of such samples;

f. A pharmaceutical company shall not supply a sample of a drug which is a hypnotic, sedative, or a tranquillizer. • Each company should maintain details such as product name, doctor name, quantity of samples given, date of supply of free samples to healthcare practitioners etc, and the monetary value of samples so distributed should not exceed two percent of the domestic sales of the company per year.

Receipt of brand reminders from pharmaceutical companies by healthcare practitioners may not be construed as endorsement activity if it does not amount to recommendation or issuance of a statement by a healthcare professional w.r.t. use of the respective brand.

The giver and recipient of brand reminders should comply with the relevant provisions of the Income Tax Act, 1961 with respect to deductions and reporting of income.

Continuing Medical Education

Engagement of pharmaceutical industry with the healthcare professionals for Continuing Medical Education (CME), Continuing Professional Development (CPD) or otherwise for conference, seminar, workshop, etc. should only be allowed through a well-defined, transparent, and verifiable set of guidelines based on which the pharmaceutical industry may undertake such expenditures.

Such activities or events should operate within the following framework:

i. Conduct of such events in foreign locations is prohibited.

ii. The following are allowed to conduct CME/CPD meetings:

a) Medical Colleges/Teaching Institutions/Universities/Hospitals

b) Professional Associations of Doctors/Specialists

c) NIPERs, Laboratories of ICMR, DBT, CSIR etc, Pharma Colleges/other academic and research institutions

d) Pharmaceutical companies, including their trusts/associations, either alone or in collaboration with professional bodies, institutions as stated in a, b & c above.

iii. All pharmaceutical companies should share the details of such events conducted by them, including the expenditures incurred thereupon, on their website, and may be subject to independent, random, or risk-based audit for this purpose.

iv. All organizers of such events should explicitly spell out the procedure followed in the selection of participants and speakers, display a statement of their funding sources and expenditures on their website, and may be subject to special audit for this purpose.

v. Entities incurring expenditure on such events, as well as participants and speakers, must comply with the relevant provisions of the Income Tax Act 1961 as amended from time to time.

Support for Research

To provide rational support and encouragement to research and innovation through the industry-academia linkage, interaction between pharmaceutical companies and healthcare professionals may be subject to the following:

i. The said study or research should be one that has the requisite approval from the competent authority (such as ICMR, DCGI, Ethics Committee, Institutional Authority etc.) and is conducted, where so applicable, at a recognized site or location. Instructions by relevant bodies like NMC, etc., may be complied with.

ii. Engagement of healthcare professionals in consultant-advisory capacity shall be for bona-fide research services, under a consultancy agreement involving a consultancyfee or an honorarium-based payment, subject to the relevant provisions of the Income-Tax Act, 1961. Such engagements should ensure the patient interest is not compromised and integrity of the healthcare professional is maintained in line with the NMC regulations.

iii. Expenditure on research by pharmaceutical companies is an allowable expenditure subject to the provisions of the Income Tax Act 1961 as amended from time to time.

Relationship with Healthcare Professionals

Gifts: No gift should be offered or provided for personal benefit of any healthcare professional or family member (both immediate and extended) by any pharmaceutical company or its agent i.e. distributors, wholesalers, retailers, etc. Similarly, no pecuniary advantage or benefit in kind may be offered, supplied, or promised to any person qualified to prescribe or supply drugs, by any pharmaceutical company or its agent i.e. distributors, wholesalers, retailers, etc.

Travel: Companies or their representatives, or any person acting on their behalf, should not extend travel facilities inside or outside the country, including rail, air, ship, cruise tickets, paid vacations, etc., to healthcare professionals or their family members (both immediate and extended) for attending conferences, seminars, workshops etc., unless the person is a speaker for a CME or a CPD Program.

Hospitality: Companies or their representatives, or any person acting on their behalf, should not extend hospitality like hotel stay, expensive cuisine, resort accommodation etc., to healthcare professionals or their family members (both immediate and extended) unless the person is a speaker for a CME or a CPD program.

Monetary Grants: Companies or their representatives should not pay cash or monetary grant to any healthcare professional or their family members (both immediate and extended) under any pretext. Where any item missing, the Code as per the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulation, 2002, as amended from time to time, will prevail.

Ethics Committee for Pharma Marketing Practices

All the Indian Pharmaceutical Associations will upload the UCPMP on their website along with the detailed procedure for lodging of complaints which will be linked to the UCPMP portal of the Department of Pharmaceuticals.

There will be a committee for handling complaints named as "Ethics Committee for Pharma Marketing Practices (ECPMP)" in each Association, chaired by its Chief Executive Officer. The Committee will have three to five members, and its composition will be approved by the Board of the Association and prominently placed on its website.

If a complaint received in a particular association is not concerned with its members, the receiving association will input the abstract of the complaint and will duly transfer the complaint to such other association where the respondent company is a member of the other association.

In case of companies, who are not members of any Association, or member of more than one Association, the complaint should ordinarily be handled by the Phaiiiia Industry Association to whom the complainant has addressed the complaint; and where necessary, it will seek guidance from the Department of Pharmaceuticals.

All pharma associations will share on their website the details of complaints received i.e. the nature of complaint, the company against whom the complaint has been made, the present status of the complaint, including action taken by the ECPMP, and such details should remain uploaded for five years. Such details should also be uploaded on the UCPMP portal of the Department of Pharmaceuticals.

Lodging of Complaints

All complaints, related to the breach of the Code should be addressed to the "Ethics Committee for Pharma Marketing Practices (ECPMP)", "Chief Executive Officer", "Name of Association".

All complaints related to an activity of breach of the Code should, to the extent practicable, be made at one time. The complaint must be made within six months of the alleged breach of the Code, with a maximum of another six months for reasonable delay that can be explained in writing. Related complaints may be clubbed together by the Ethics Committee to save time and expedite disposal.

Complaints must be in writing and for each case The Complainant should: i. identify himself (whether a company, entity or an individual) with a full mailing address (email and mobile telephone no). ii. identify the company, which is alleged to have breached the Code, including the name of any company personnel, product, or products, which are specifically involved. iii. give the details of the activity which is alleged to be in breach of the Code, give the date of the alleged breach, clauses of the Code which are alleged to have been breached, and provide supporting evidence of the alleged breach(es).

A non-refundable amount of Rs. 1,000/is to be deposited by the complainant along with the complaint. The respective association will elaborate on their website how this payment is to be made. No pseudonymous or anonymous complaints or those made without the prescribed fee will be entertained.

When the complaint is from a pharmaceutical company, the complaint must be signed or authorized in writing by the company's managing director or chief executive officer or a person at an equivalent level.

When it appears from media reports (other than letters to the editor of a publication) that a company may have breached the Code, the matter may be treated as complaint, and the committee may request the concerned publication for further information, and the source or the correspondent may be treated as the complainant.

Any complaint received by the Department of Pharmaceuticals may also be forwarded to the concerned Association for necessary action. In such cases, the concerned Association will take up the matter further with the complainant concerned. The Department may order a special audit for the purpose.

Handling of Complaints

Once a complaint is lodged, the process of enquiry should be taken up and completed by the ECPMP. The decision of the Committee will be made by majority. In case of conflict of interest, the member/s concerned should recuse themselves from the proceedings.

When the Committee receives information from which it appears that a company may have contravened the Code, the managing director or chief executive officer of the company concerned will be asked to provide a complete response to the matter.

To assist companies in ensuring that a complete response is submitted, the Committee may suggest to the respondent company the relevant supporting material to be supplied, and it shall be the responsibility of the respondent company to ensure that a full response is submitted within the stipulated timeframe.

Associations may engage the services of professional auditors to facilitate better and independent examination towards arriving at an informed decision.

The respondent company shall submit its comments and supporting documents to the Committee in not more than 30 days after receipt of notice from the Committee.

The company against which the complaint is made should provide supporting evidence even if it thinks that the Code has not been breached.

The Committee should render a decision within 90 days of the receipt of complaint, and having done so, it should promptly notify the parties of its decision, the reasons thereof in writing and send it by recorded mail.

Where the Committee decides there is no breach of the Code, or that matter of complaint is not within the scope of the Code, the complainant will be so advised in writing, including advice on the appropriate forum to approach in such cases.

Where the Committee, after enquiry, decides that there is a breach of the Code, the complainant and the respondent company will be so advised in writing, including the remedial steps that need to be taken in this regard.

If no appeal is filed within the stipulated period, the decision of the ECPMP shall be final and binding, and adherence to such decision shall be a condition of continued membership of the Association. The decisions shall also be uploaded on the website of the Association and the Department of Pharmaceuticals.

Penalties and Reference

Once it is established that a breach of the Code has been made by an entity, the Committee can propose one of the following actions against the erring entity:

i. To suspend or expel the entity from the Association.

ii. To reprimand the entity and publish full details of such reprimand.

iii. To require the entity to issue a corrective statement in the same media (and other suitable media) which was used to issue promotional material, textual or audio-visual (details of the proposed content, mode and timing of dissemination of the corrective statement must be provided by the entity to the Committee for prior approval).

iv. To ask the entity to recover money or items, given in violation of the Code, from the concerned personls, and details of the action taken in this regard must be submitted by the entity to the Committee in writing.

v. In cases where disciplinary, penal, or remedial action lies within the domain of any agency or authority of the Government in accordance with the statute, the Committee may send its recommendations to such agency or authority through the Department of Pharmaceuticals.

Appeal

If a party to the complaint is dissatisfied with the decision of the ECPMP, it may file an appeal before an Apex Committee for Pharma Marketing Practices (ACPMP) headed by the Secretary, Department of Pharmaceuticals, having a Joint Secretary and a Finance Officer dealing with the subject as its members. Explanation: The expression 'party to the complaint' means the complainant or the respondent entity, and the expression 'decision of the ECPMP' includes a lack of decision thereof, or inordinate delay in reaching such a decision.

The time limit for filing such an appeal will ordinarily be 15 days, with an additional 15 days of reasonable time delay permitted for reasons to be recorded in writing.

The ACPMP will give a notice to both the parties, and after giving a reasonable opportunity of being heard, give a final decision or ruling within six months.

The ACPMP may prescribe any penalties or make a reference to an appropriate agency or an authority of the Government in accordance with para- 12 above.

The decision in appeal shall be final and binding on both the parties.

Miscellaneous

The Department of Pharmaceuticals may, for furtherance of the provisions of this Code, or for removal of difficulties in its operation, may issue standing orders from time to time which will be considered an integral part of this Code.

The provisions of this Code, unless exempted, or to the extent modified by standing orders, shall apply mutatis mutandis to medical devices and companies or entities manufacturing or dealing with the sale and distribution of such products.

The Department of Pharmaceutical will notifv a panel of auditors, either audit firms of standing empanelled by the CAG or commercial audit firms of repute having an experience of dealing with such matters.

Finally, the Chief Executive Officer of the company itself is responsible for adherence to this Code, and a self-declaration in the format given in the annexure shall be submitted by the executive head of the company within two months of the end of every financial year to the Association for uploading on their website, or directly on the UCPMP portal of the Department of Pharmaceuticals in case he is not a member of such a body, or a member of more than one such bodies.

To view the official notification, click on the link below:

https://medicaldialogues.in/pdf_upload/ucpmp-2024-234201.pdf

1 year 1 month ago

News,Health news,Doctor News,Industry,Pharma News,Top Industry News,Notifications

Health News Today on Fox News

New Jersey twins receive matching heart surgeries after Marfan syndrome diagnosis: 'A better life'

The notion that twins do everything together has met a new standard.

Identical twin brothers Pablo and Julio Delcid, 21, underwent matching heart surgeries on the exact same day following their diagnosis of Marfan syndrome.

The notion that twins do everything together has met a new standard.

Identical twin brothers Pablo and Julio Delcid, 21, underwent matching heart surgeries on the exact same day following their diagnosis of Marfan syndrome.

The duo, of Dover, New Jersey, had been alerted to their risk of Marfan syndrome because a majority of their family members also have it, the twins told Fox News Digital in an on-camera interview.

FOUR TEXAS RESIDENTS FOREVER CONNECTED BY TWO KIDNEY DONATIONS IN DIFFERENT CITIES: 'SUPERBLY TIMED'

"We're a family of five. I have two older sisters who have it," Julio Delcid said. "My older brother doesn't have it as much ... But I also have other family members who have it, too — pretty much through my whole family on my mom’s side."

"It's very genetic," Pablo Delcid added. "When we were younger and were first diagnosed with it, nobody knew what it was." 

He added, "Nobody knew they even had it until tests kept coming in, and they were like, ‘Yeah, it's pretty genetic. Everyone should get tested.'"

Fox News Digital spoke with Dr. Benjamin Van Boxtel, surgical director at the Atlantic Aortic Center at Morristown Medical Center, in a separate interview about the condition; he performed the twins’ surgeries.

The cardiovascular surgeon said that while Marfan syndrome is mostly genetic, it can also occur at random. It's a defect of the gene that creates connective tissues in the human body, he said.

FLORIDA STUDENT AND TEACHER BOND OVER MATCHING SCARS FROM THEIR OPEN-HEART SURGERIES: 'TOUGH COOKIES'

"Because it's a broad defect in these connective tissues, it can affect many different parts of the body," he said. "So, this could be anywhere from the eyes to the spine and … the heart."

"The most dangerous symptom you could develop with Marfan syndrome is a dilation of the aorta, specifically in the root," he added.

Van Boxtel said the aortic root in Marfan syndrome can become dilated or enlarged, which can cause an "immediately fatal" tear or rupture.

"Or it can cause something called an aortic dissection, which is also potentially very fatal, and becomes a surgical emergency," he said. "That's unfortunately how a lot of people who have Marfan syndrome pass away."

Many of those people don't even know they have the syndrome, Van Boxtel noted.

A valve-sparing root procedure performed before a dilated aorta dissects can be a life-saving operation.

TWO WOMEN WITH HEART DISEASE HAD TO FIGHT FOR A DIAGNOSIS. HERE’S HOW THEY ADVOCATED FOR THEIR HEALTH

Marfan syndrome can be difficult to spot, according to Van Boxtel, as it's often marked by common symptoms such as chest pain, poor vision — or being tall and having long limbs.

"When you have an aneurysm [from a] dilated aorta, it's generally asymptomatic, meaning you feel absolutely nothing," he said. "You feel completely fine … Aneurysm disease is silent, it's asymptomatic — which can be really dangerous."

Pablo Delcid, for his part, said there’s "not much you can feel when you're growing into the condition."

He added, "What we didn't know was that our bodies were changing … obviously with height, vision, the length of our arms, feet, legs, even with our chest."

The twins’ mother, Betulia Miranda, had an emergency procedure on Oct. 8, 2023, after experiencing an aortic dissection, which the boys described as "excruciating" for her.

After their mother's surgery was a success, the twins decided to seek preventative surgery performed by Dr. Van Boxtel – but their one request was that they do it together.

"Of course they’re like, ‘Can we go at the same time?’" the doctor said with a laugh.

FLORIDA BRAIN TUMOR PATIENT PLAYS GUITAR DURING HIS SURGERY: ‘THIS IS WILD’

Van Boxtel, a father of twins himself, said the double surgery was like "nothing I've ever done before." 

He said, "I've done this procedure hundreds of times. But to do it back-to-back on twin brothers — it was an experience, that's for sure."

It was decided that Pablo Delcid would go first, since he was born five minutes before his brother, followed by Julio Delcid several hours later.

"We always do everything together," Pablo Delcid said. "We live together, go through everything together … We didn't think we could get the operation done together, but everything [was] successful."

The twins agreed that they felt "safer" knowing they were going through the procedure together.

"You kind of feel like you're not going to lose that person," Julio Delcid said. "They're sticking with you, side by side."

Pablo Delcid added, "It’s like your gut’s telling you, ‘All right, if I make it, he's going to make it.’"

On surgery day, Jan. 5, 2024, Van Boxtel and his team distinguished the twins from one another using color-coded ankle bracelets.

The surgeon emphasized the rarity of double heart surgery on twins, especially at such a young age of 21. "This is like the ultimate twin study," he said. 

Van Boxtel said it was "freaky" when he realized that the brothers' hearts were also identical.

"I knew they could be different on the inside, but it ended up that they were the exact same," he said.

Julio Delcid said he was "shocked" that a surgeon like Van Boxtel could take on both surgeries back to back.

"He did the best he could," he said. "He successfully saved our aortic valves, replacing the aneurysm … We were very appreciative."

Marfan syndrome affects about one in 5,000 people, according to Van Boxtel, and impacts men and women equally.

"About 75% of those cases are genetic," he said. "But about 25% of Marfan cases are actually not inherited. They're not from a parent. They're a spontaneous mutation."

ONE FAMILY DONATES FOUR KIDNEYS TO SAVE A NEW YORK MAN’S LIFE: ‘DEFIED ALL ODDS’

Along with a dilated aortic root (enlarged aorta) or narrow dissection (tear in an artery), patients also run the risk of having a leaky valve, which can lead to heart failure symptoms like shortness of breath, chest pain, dizziness and inability to perform normal exertional activity, Van Boxtel said. 

Since Marfan syndrome is often hard to spot on the surface, the Delcid twins emphasized the importance of getting tested, especially for those within the Latin and Hispanic communities.

"It's pretty lethal," Pablo Delcid said. "We almost lost our mother, and that was a traumatic experience."

People with symptoms or with a family history of Marfan syndrome should educate themselves on how best to prevent an aneurysm and connect with a cardiology team, Julio Delcid reiterated.

ARIZONA STUDENTS RAISE NEARLY $10K FOR HEART SURGERY FOR TEACHER'S WIFE: 'MADE ME CRY'

"It’s just very important to take the time and the opportunity to get the best treatment that they could possibly get, because if they wait, consequences will happen later," he said.

"Don't fear anything. Just take the time to get yourself checked out and get the help that you need to live a better life."

With the stresses of heart surgery behind them, the twins said they're looking forward to getting outside, playing sports and exercising more than they could before.

"Both their valves were saved," Van Boxtel said. "They weren't leaking at the end. All the things that we look for in a very successful repair they had, and they're going to go on and live normal, healthy lives."

He said he hoped that "these valves last a really, really long time, if not the rest of their lives. They're much better off now than they were walking around with aneurysms."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Van Boxtel thanked his team for handling the complex, same-day operations on young men with their "whole lives ahead of them."

The Marfan Foundation has various resources for patients at all stages of the condition, the doctor noted.

"I can't underscore how important it is for patients with aneurysms to be seen by a surgeon or a team who is comfortable performing that," he said.

"It's a very, very serious problem … but there's prevention available, and if you get it at the right time, it can be very successful."

For more Health articles, visit www.foxnews.com/health.

1 year 1 month ago

heart-health, Health, lifestyle, Surgery, new-jersey, family, rare-diseases, medical-mysteries-marvels, health-care

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

NMC gives deadline to 320 Students with Pending Eligibility Certificate Applications, issues warning

New Delhi: Through a recent notice, the National Medical Commission (NMC) has released a list of 320 medical students whose applications for eligibility certificates are pending due to various deficiencies and given a deadline for them to rectify such deficiencies.

The Ethics and Medical Registration Board (EMRB) of NMC informed in the notice that these applicants have been informed about the deficiencies in their applications more than 5 times. However, despite this, the concerned deficiencies remain unaddressed by the applicants.

Therefore, by releasing the list of applicants, along with their name, father's name, and application tracking number, the Apex Medical Commission has asked them to rectify the deficiencies by March 22, 2024.

NMC clarified that after the deadline, it would not entertain those applications any more and close them for inaction on the part of such applicants.

"With regard to pending online applications for grant of Eligibility Certificate, it has been observed that as on date 320 applicants are lying pending with the applicants despite repeated intimation of the deficiency to the respective applicants more than 5 times the deficiencies pointed out continue to remain unaddressed by the applicants. A list of such applications with tracking no is attached for ready reference," the Ethics Board of NMC mentioned in the notice dated 12.03.2024.

"It is requested that the deficiencies conveyed may please be rectified at the earliest latest by 22nd March, 2024. No correspondence in connection with these applications will be entertained after 22nd March 2024 and all such applications will be closed thereafter. for inaction on the part of such applicants," the Commission clarified.

Medical Dialogues had earlier reported that recently, NMC issued an advisory regarding the eligibility certificates for the FMGs. Referring to the mistakes by the candidates while applying for Eligibility Certificates, the Ethics Board of NMC mentioned in the Advisory, "It has also been observed on previous occasions that various mistakes are made by the candidates while applying for the Eligibility Certificate (EC)."

The Commission suggested the following measures to avoid mistakes:

(i) The applications should preferably be filled by the candidate himself and should ideally avoid proxy for making applications for EC:

(ii) The candidates are also advised to keep their documents handy before filling application for EC; it would be ideal if the entries to be made are verified vis-a-vis entries in the original documents;

(iii) The candidates should provide their active mobile numbers so that alerts/deficiencies can reach them directly for rectification to obviate any delay in rectification. It may also be ensured that once the deficiency is conveyed only the deficiency should be rectified by the respective candidate as expeditiously as possible to avoid last minute rush; and

(iv) Candidates shall scrupulously check entries and ensure conformity with the details in the original documents to ensure quick processing/approval of applications if otherwise eligible.

"The above-mentioned steps are only suggestive and not exhaustive. Candidates are requested to exercise due diligence before submitting applications for Eligibility Certificates and ensure the mobile numbers indicated remain active," clarified the Commission.

To view the NMC notice, click on the link below:

https://medicaldialogues.in/pdf_upload/nmc-eligibility-certificates-234177.pdf

Also Read: NMC Invites Applications for Eligibility Certificate for FMGE, details

1 year 1 month ago

State News,News,Health news,Delhi,NMC News,Medical Education,Top Medical Education News,Notifications,Latest Education News

Health

Why do you need self-care?

SELF-CARE MEANS taking care of yourself so that you can be healthy, well, be able do your job, care for others, and do all the things you need to and want to accomplish in a day. If you think you have been hearing more about self-care lately, you...

SELF-CARE MEANS taking care of yourself so that you can be healthy, well, be able do your job, care for others, and do all the things you need to and want to accomplish in a day. If you think you have been hearing more about self-care lately, you...

1 year 1 month ago

Pages